Healthcare & Medical Devices Global On demand · 24-48h

Global Intermittent Pneumatic Antithrombotic Pump Market Strategic Research Report

Global Intermittent Pneumatic Antithrombotic Pump Market Str…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Intermittent Pneumatic Antithrombotic Pump Market
$1.03B2025
7.3%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Desktop Pump, Vertical Pump

By Application: Hospitals and Clinics, Rehabilitation Center, Household

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Cardinal Health, Arjo, Dsmaref, Enovis (DJO), WONJIN MULSAN, Medline Industries, BTL Industries, Zimmer Biomet, Breg, Inc., OPED GmbH, Lifotronic Technology, XiangyuMedical, Labtek, Comen, Beoka, Shenzhen In Situ Medical Equipment

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 142 pages
Market size 2025
$1.03B
Billion USD
Forecast CAGR
7.3%
2025-2032
Forecast 2032
$1.7B
Projected
Области
5
Asia Pacific · Latin America · MEA · Europe · North America

Обзор

Scope of the Report

The global Intermittent Pneumatic Antithrombotic Pump market size is predicted to grow from US$ 1,029 million in 2025 to US$ 1,669 million in 2032; it is expected to grow at a CAGR of 7.3% from 2026 to 2032.

In 2025, global Intermittent Pneumatic Antithrombotic Pump production reached approximately 1.34 million units, with an average global market price of around US$785 per unit. Intermittent Pneumatic Antithrombotic Pump, commonly referred to as an Intermittent Pneumatic Compression (IPC) device or a DVT pump, is a medical device used to prevent dangerous blood clots—such as deep vein thrombosis (DVT) and pulmonary embolism (PE).

Intermittent Pneumatic Antithrombotic Pump is an important subcategory of preventive devices in the global medical device market, and its market demand is directly related to the improvement of the global medical service system. Regional market development shows significant differentiation. The North American market is mature with complete clinical application specifications, unified procurement and use standards in medical institutions, and high market penetration. The European market, affected by strict medical regulatory systems and extensive medical insurance coverage, mainly demands high-end intelligent models with strict requirements for equipment safety and comfort. The Asia-Pacific region is the fastest-growing market globally. Accelerated medical infrastructure construction and improved clinical awareness in emerging economies drive market demand release. China's market, with its large population base and the trend of medical resource sinking, becomes the core growth engine in the Asia-Pacific region.

The market competition pattern shows a head-concentrated feature. European and American multinational enterprises dominate the global high-end market through long-term technical accumulation and global sales networks. Their products maintain competitive advantages through continuous technological iteration and gain long-term recognition from medical institutions relying on perfect after-sales systems. Chinese local enterprises occupy the main share in the mid-to-low-end market by virtue of local manufacturing advantages and cost control capabilities, gradually improve product technical levels, enter overseas markets through international certifications, and continue to expand product export scale.

Industry development is driven by both medical policies and clinical needs. Major global economies have incorporated venous thromboembolism prevention into clinical diagnosis and treatment guidelines, promoting medical institutions to configure relevant equipment. Accelerated population aging and rising prevalence of chronic diseases increase clinical demand for thrombosis prevention. Technological iteration promotes products to develop towards miniaturization, intelligence and portability, improving clinical convenience and patient compliance, and further expanding product application scenarios.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Intermittent Pneumatic Antithrombotic Pump market?

What factors are driving Intermittent Pneumatic Antithrombotic Pump market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Intermittent Pneumatic Antithrombotic Pump market opportunities vary by end market size?

How does Intermittent Pneumatic Antithrombotic Pump break out by Type, by Application?

This report presents a comprehensive overview of the global Intermittent Pneumatic Antithrombotic Pump market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Desktop Pump
  • Vertical Pump

Segment by Technology

  • Sequential Gradient Compression
  • Uniform Intermittent Compression

Segment by Chambers

  • <8 Chambers
  • 8-16 Chambers
  • >16 Chambers

Segment by Application

  • Hospitals and Clinics
  • Rehabilitation Center
  • Household

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Intermittent Pneumatic Antithrombotic Pump market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospitals and Clinics, Rehabilitation Center, Household evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Intermittent Pneumatic Antithrombotic Pump Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 7.3%
Regional growth momentum
Market share by segment
Key metrics
Base value
$1.03B
2025
Forecast
$1.7B
2032
CAGR
7.3%
2025–2032
Области
5
global
Key companies
Cardinal HealthArjoDsmarefEnovis (DJO)WONJIN MULSANMedline IndustriesBTL IndustriesZimmer Biomet
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Desktop PumpVertical Pump
By Application
Hospitals and ClinicsRehabilitation CenterHousehold

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Desktop Pump
  • 3.1.3 Vertical Pump
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospitals and Clinics
  • 4.1.3 Rehabilitation Center
  • 4.1.4 Household
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Cardinal Health
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Arjo
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Dsmaref
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Enovis (DJO)
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 WONJIN MULSAN
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Medline Industries
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 BTL Industries
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Zimmer Biomet
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Breg, Inc.
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 OPED GmbH
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Lifotronic Technology
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 XiangyuMedical
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Labtek
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Comen
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Beoka
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Shenzhen In Situ Medical Equipment
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Intermittent Pneumatic Antithrombotic Pump market size?
The global Intermittent Pneumatic Antithrombotic Pump market is estimated at US$ 1.03 billion in 2025 (base year) and is projected to reach US$ 1.67 billion by 2032.
What growth rate is expected for the Intermittent Pneumatic Antithrombotic Pump market through 2032?
The market is expected to grow at a CAGR of 7.3% from 2026 to 2032, expanding from US$ 1.03 billion in 2025 to US$ 1.67 billion in 2032, roughly 1.6 times its base-year value.
How is Intermittent Pneumatic Antithrombotic Pump defined?
In 2025, global Intermittent Pneumatic Antithrombotic Pump production reached approximately 1.34 million units, with an average global market price of around US$785 per unit. Intermittent Pneumatic Antithrombotic Pump, commonly referred to as an Intermittent Pneumatic Compression (IPC) device or a DVT pump, is a medical device used to prevent dangerous blood clots—such as deep vein thrombosis (DVT) and pulmonary embolism (PE).
What are the main segments of the Intermittent Pneumatic Antithrombotic Pump market by type?
By type, the market is segmented into Desktop Pump and Vertical Pump.
Which applications drive demand in the Intermittent Pneumatic Antithrombotic Pump market?
Key applications covered include Hospitals and Clinics, Rehabilitation Center and Household.
Who are the key players in the Intermittent Pneumatic Antithrombotic Pump market?
Key players profiled include Cardinal Health, Arjo, Dsmaref, Enovis (DJO), WONJIN MULSAN, Medline Industries, BTL Industries and Zimmer Biomet, among 16 companies covered in total.
Which regions and countries are covered for Intermittent Pneumatic Antithrombotic Pump?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Intermittent Pneumatic Antithrombotic Pump market?
Industry development is driven by both medical policies and clinical needs.
Who should buy the Intermittent Pneumatic Antithrombotic Pump market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospitals and Clinics, Rehabilitation Center and Household, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Intermittent Pneumatic Antithrombotic Pump market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3 500,00 $
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.